Acumen Pharmaceuticals (ABOS)

• Market cap: $172M
• 1 day: 1.71%
• 5 days: 8.68%
• 1 month: 9.17%
• 3 months: -28.74%
• 6 months: 13.33%
• Year to date: 17.82%
• 1 year: 108.77%
• 5 years: -88.16%
• 10 years: -88.16%
• Sector: Healthcare
• Industry: Biotechnology

About: Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease. The company's drug candidate, ACU193, is a subclass monoclonal antibody that selectively targets amyloid-beta oligomers. The product pipelines include: ALTITUDE-AD; and INTERCEPT-AD.

Employees: 61